Glympse Bio, Inc.

Calculating rank

USPTO Granted Patents = 4

Trademarks = 1

Forward Citations = 5

Loading Chart...

10 inventors (with patents filed for the assignee):

Sophie Cazanave (4 out of 6 patents)

Sangeeta N Bhatia (2 out of 61 patents)

Sirshendu Roopom Banerjee (2 out of 3 patents)

4. Eric Huang (2 out of 2 patents)

5. Andrew Warren (2 out of 8 patents)

6. Gabriel A Kwong (2 out of 16 patents)

7. Mehar Cheema (2 out of 4 patents)

8. Wendy Winckler Adamovich (2 out of 5 patents)

9. Faycal Touti (2 out of 4 patents)

10. Robert Samuel Langer (2 out of 636 patents)

4 patents: Sort by Forward Citations

1. 11851697 - Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment (2023-12-26),

2. 11732009 - Activity sensor with tunable analyte (2023-08-22),

3. 11604193 - Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment (2023-03-14),

4. 11028425 - Diagnosis and monitoring of liver disease (2021-06-08),

Company Overview

Glympse Bio, Inc. is a biotechnology company focused on developing non-invasive diagnostic technologies for various diseases. They specialize in utilizing proprietary nanoparticle technology to detect and monitor biomarkers in the body, enabling early disease detection and personalized treatment. The company's innovative approach has the potential to revolutionize healthcare by providing more accurate and timely diagnostic solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#412 in Cambridge, MA

#3,316 in Massachusetts

#60,704 in US

Cambridge, MA, United States of America

Glympse Bio, Inc.

Forward Citations = 5

10 inventors:

Sophie Cazanave (4 out of 6 patents)

Sangeeta N Bhatia (2 out of 61 patents)

Sirshendu Roopom Banerjee (2 out of 3 patents)

4. Eric Huang (2 out of 2 patents)

5. Andrew Warren (2 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Glympse Bio, Inc.. Retrieved from https://idiyas.com/company/glympse-bio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]